Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
43 |
|
2001 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.929 |
14 |
|
2009 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.929 |
14 |
|
2009 |
2019 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2015 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2015 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Inflammatory Bowel Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1577
|
605
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms, Glandular and Epithelial
|
group |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
68
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sarcoma of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
258
|
6
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.070 |
None |
1.000 |
7 |
|
2000 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.070 |
None |
1.000 |
7 |
|
2012 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Post MI
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
203
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.090 |
None |
1.000 |
9 |
|
2016 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.080 |
None |
1.000 |
8 |
|
2000 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.060 |
None |
1.000 |
6 |
|
2000 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.040 |
None |
0.750 |
4 |
|
2013 |
2018 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |